Search results
Showing 106 to 120 of 131 results for urinary incontinence
Irreversible electroporation for treating prostate cancer (IPG768)
Evidence-based recommendations on irreversible electroporation for treating prostate cancer. This involves using electrical pulses to destroy the cancer cells.
View recommendations for IPG768Show all sections
Insertion of biological slings for stress urinary incontinence in women (IPG154)
This guideline has been updated and replaced by NICE guideline NG123.
Suburethral synthetic sling insertion for stress urinary incontinence in men (IPG256)
This guidance has been withdrawn as the use of this procedure is now covered in NICE guideline CG97. NICE has no plans to carry out further assessment of this procedure under the Interventional procedures programme.
Evidence-based recommendations on biodegradable spacer insertion to reduce rectal toxicity during radiotherapy for prostate cancer. This involves pushing the rectum slightly away from the prostate by inserting a balloon or injecting a gel (spacer) between them.
View recommendations for IPG752Show all sections
This guideline covers rehabilitation after stroke for over 16s. It aims to ensure people are assessed for common problems and conditions linked to stroke, and get the care and therapy they need. It includes recommendations on the organisation and delivery of rehabilitation in hospital and the community.
Single-incision sub-urethral short tape insertion for stress urinary incontinence in women (IPG262)
This guidance has been updated and replaced by NICE interventional procedure guidance 566.
This guidance has been updated and replaced by NICE interventional procedures guidance 576.
This guidance has been withdrawn as the use of this procedure is now covered in NICE guideline CG97. NICE has no plans to carry out further assessment of this procedure under the Interventional Procedures Programme.
Padeliporfin for untreated localised prostate cancer (TA546)
Evidence-based recommendations on padeliporfin (Tookad) for untreated, unilateral, low-risk prostate cancer in adults.
Peristeen Plus transanal irrigation system for managing bowel dysfunction (MTG36)
Evidence-based recommendations on Peristeen Plus transanal irrigation system for managing bowel dysfunction.
CG139/3 | Intermittent urinary catheters: catheter selection:- For patients performing intermittent self-catheterisation
A quick guide to promoting positive mental wellbeing for older people
This guideline covers the care of women and their babies during labour and immediately after birth. It focuses on women who give birth between 37 and 42 weeks of pregnancy (‘term’). The guideline helps women to make informed choices about where to have their baby and about their care in labour. It also aims to reduce variation in aspects of care.
View recommendations for NG235Show all sections
Sections for NG235
- Overview
- Recommendations
- Recommendations for research
- Rationale and impact
- Context
- Appendix A: Adverse outcomes for different places of birth
- Appendix B: Outcomes for different places of birth – by BMI at booking
- Appendix C: Outcomes for intravenous remifentanil patient-controlled analgesia (PCA) compared with intramuscular pethidine
Spinal metastases and metastatic spinal cord compression (NG234)
This guideline covers recognition, referral, investigation and management of spinal metastases and metastatic spinal cord compression (MSCC). It is also relevant for direct malignant infiltration of the spine and associated cord compression. It aims to improve early diagnosis and treatment to prevent neurological injury and improve prognosis.
NICE has developed a medtech innovation briefing (MIB) on the Secca System for faecal incontinence